Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer

Update Il y a 4 ans
Reference: NCT00527930

Woman and Man

Extract

Phase II trial of oxaliplatin in combination with S-1(SOX) in patients with recurrent or metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline and taxane


Inclusion criteria

  • Breast Neoplasms

Links